Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$147M |
| 2 |
NVIDIA
NVDA
|
+$129M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$124M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$109M |
| 5 |
INFN
Infinera Corporation Common Stock
INFN
|
+$98.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$97.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$93.9M |
| 3 |
UnitedHealth
UNH
|
+$68.8M |
| 4 |
Salesforce
CRM
|
+$57M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$56.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.46% |
| 2 | Financials | 3.89% |
| 3 | Industrials | 3.8% |
| 4 | Consumer Discretionary | 3.36% |
| 5 | Healthcare | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Delek US
DK
$4.16B
| $915K | ﹤0.01% |
48,798
-98,971
| -67% | -$2.09M |
|
1677
CALL
BioMarin Pharmaceuticals
BMRN
$12.8B
| $914K | ﹤0.01% |
+13,000
| New | +$1.09M |
|
|
MRO
1678
DELISTED
Marathon Oil Corporation
MRO
| $912K | ﹤0.01% |
34,255
+879
| +3% | +$24.3K |
|
|
SRG
1679
Seritage Growth Properties
SRG
$119M
| $912K | ﹤0.01% |
196,107
+7,524
| +4% | +$35.2K |
|
1680
PUT
VeriSign
VRSN
$26.1B
| $912K | ﹤0.01% |
4,800
-1,500
| -24% | -$271K |
|
1681
Portland General Electric
POR
$5.86B
| $909K | ﹤0.01% |
+18,983
| New | +$888K |
|
1682
Evergy
EVRG
$18.8B
| $908K | ﹤0.01% |
14,641
-54,590
| -79% | -$3.18M |
|
1683
ATN International
ATNI
$476M
| $906K | ﹤0.01% |
28,016
-9,394
| -25% | -$247K |
|
1684
PUT
GXO Logistics
GXO
$5.42B
| $906K | ﹤0.01% |
+17,400
| New | +$882K |
|
1685
Phreesia
PHR
$717M
| $905K | ﹤0.01% |
+39,731
| New | +$930K |
|
1686
Liberty Live Group Series C
LLYVK
$9.78B
| $902K | ﹤0.01% |
17,575
| – | – |
|
1687
iShares Russell Top 200 Growth ETF
IWY
$15.8B
| $896K | ﹤0.01% |
+4,074
| New | +$867K |
|
1688
MannKind Corp
MNKD
$1.35B
| $896K | ﹤0.01% |
142,469
+6,576
| +5% | +$37.8K |
|
1689
PUT
Transmedics
TMDX
$3.21B
| $895K | ﹤0.01% |
+5,700
| New | +$878K |
|
1690
CALL
American International
AIG
$40B
| $893K | ﹤0.01% |
12,200
+5,000
| +69% | +$373K |
|
1691
CALL
Cracker Barrel
CBRL
$1.27B
| $893K | ﹤0.01% |
19,700
+2,700
| +16% | +$111K |
|
1692
PUT
ON Semiconductor
ON
$28.1B
| $893K | ﹤0.01% |
12,300
-36,400
| -75% | -$2.65M |
|
1693
Gogo Inc
GOGO
$356M
| $888K | ﹤0.01% |
123,672
+68,017
| +122% | +$555K |
|
1694
SITE Centers
SITC
$159M
| $888K | ﹤0.01% |
+75,223
| New | +$883K |
|
1695
Snap
SNAP
$9.57B
| $887K | ﹤0.01% |
82,942
-662,203
| -89% | -$7.55M |
|
1696
CareDx
CDNA
$2.55B
| $887K | ﹤0.01% |
28,399
+7,473
| +36% | +$186K |
|
1697
PUT
Watsco Inc
WSO
$12.4B
| $885K | ﹤0.01% |
+1,800
| New | +$865K |
|
1698
PUT
Accenture
ACN
$114B
| $884K | ﹤0.01% |
2,500
-21,600
| -90% | -$7.1M |
|
1699
PUT
Leidos
LDOS
$17B
| $880K | ﹤0.01% |
5,400
-2,400
| -31% | -$363K |
|
1700
CALL
Robinhood
HOOD
$99B
| $878K | ﹤0.01% |
37,500
-40,000
| -52% | -$843K |
|
Similar funds
Paul Tudor Jones's Q3 2024 Portfolio in Review
As of Q3 2024, Paul Tudor Jones held 3,231 positions worth $27.5B, up 41% from $19.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Paul Tudor Jones deployed $6.72B of net new capital in Q3 2024, opening 973 new positions and adding to 833 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 686,581 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 8.7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Apple, an estimated $97.9M trimmed.
- Paul Tudor Jones's largest Q3 2024 buy was iShares Russell 2000 ETF: 686,581 shares worth $152M.
- Paul Tudor Jones added most to NVIDIA in Q3 2024, an estimated $129M increase.
- Paul Tudor Jones's biggest Q3 2024 reduction was Apple, cutting an estimated $97.9M.
- Paul Tudor Jones fully exited Bristol-Myers Squibb in Q3 2024, selling an estimated $93.9M.
- Paul Tudor Jones's ten largest holdings make up 47% of its $27.5B portfolio in Q3 2024.
- Paul Tudor Jones opened 973 new positions and closed 594 in Q3 2024.
- Paul Tudor Jones's portfolio value rose 41% quarter-over-quarter to $27.5B.
Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.